Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Lestrate

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical and Vaccine Immunology : CVI|November 1, 2013
Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adultsJohan Berglund, Peter Vink, Fernanda Tavares Da Silva, et al.
FEMS Microbiology Letters|February 26, 2004
Brucella pathogenesis, genes identified from random large-scale screensRose-May Delrue, Pascal Lestrate, Anne Tibor, et al.
Infection and Immunity|July 23, 2008
Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein DMaija Toropainen, Anna Raitolehto, Isabelle Henckaerts, et al.
Clinical and Vaccine Immunology : CVI|November 6, 2009
Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccinesJan T Poolman, Carl E Frasch, Helena Käyhty, et al.
Infection and Immunity|March 16, 2002
Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigenAyman Al-Mariri, Anne Tibor, Pascal Lestrate, et al.
Human Vaccines & Immunotherapeutics|February 26, 2015
Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trialJack Levy, Laurent Licini, Edwige Haelterman, et al.
Clinical and Vaccine Immunology : CVI|May 20, 2011
Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assayJan T Poolman, Isabel De Vleeschauwer, Nathalie Durant, et al.
Infection and Immunity|August 23, 2005
Systematic targeted mutagenesis of Brucella melitensis 16M reveals a major role for GntR regulators in the control of virulenceValérie Haine, Audrey Sinon, Frédéric Van Steen, et al.
Infection and Immunity|May 16, 2002
Identification of a quorum-sensing signal molecule in the facultative intracellular pathogen Brucella melitensisBernard Taminiau, Mavis Daykin, Simon Swift, et al.
BMC Microbiology|October 31, 2018
Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzaeStephen R Thomas, Stephanie Leung, Katy Knox, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical and Vaccine Immunology : CVI|November 1, 2013
Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adultsJohan Berglund, Peter Vink, Fernanda Tavares Da Silva, et al.
FEMS Microbiology Letters|February 26, 2004
Brucella pathogenesis, genes identified from random large-scale screensRose-May Delrue, Pascal Lestrate, Anne Tibor, et al.
Infection and Immunity|July 23, 2008
Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein DMaija Toropainen, Anna Raitolehto, Isabelle Henckaerts, et al.
Clinical and Vaccine Immunology : CVI|November 6, 2009
Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccinesJan T Poolman, Carl E Frasch, Helena Käyhty, et al.
Infection and Immunity|March 16, 2002
Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigenAyman Al-Mariri, Anne Tibor, Pascal Lestrate, et al.
Human Vaccines & Immunotherapeutics|February 26, 2015
Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trialJack Levy, Laurent Licini, Edwige Haelterman, et al.
Clinical and Vaccine Immunology : CVI|May 20, 2011
Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assayJan T Poolman, Isabel De Vleeschauwer, Nathalie Durant, et al.
Infection and Immunity|August 23, 2005
Systematic targeted mutagenesis of Brucella melitensis 16M reveals a major role for GntR regulators in the control of virulenceValérie Haine, Audrey Sinon, Frédéric Van Steen, et al.
Infection and Immunity|May 16, 2002
Identification of a quorum-sensing signal molecule in the facultative intracellular pathogen Brucella melitensisBernard Taminiau, Mavis Daykin, Simon Swift, et al.
BMC Microbiology|October 31, 2018
Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzaeStephen R Thomas, Stephanie Leung, Katy Knox, et al.
Pageof 2